Circle's historic IPO raises $1.1B, with shares surging over 200% on NYSE debut, signaling growing mainstream and institutional interest in stablecoins.
MHRA warns women of pregnancy risks with weight-loss drugs like Ozempic and Mounjaro.
Brown-Forman forecasts sales and profit declines amid tariff uncertainty and soft consumer spending.
Circle's historic IPO raises $1.1B, with shares surging over 200% on NYSE debut, signaling growing mainstream and institutional interest in stablecoins.
MHRA warns women of pregnancy risks with weight-loss drugs like Ozempic and Mounjaro.
Brown-Forman forecasts sales and profit declines amid tariff uncertainty and soft consumer spending.